Drug prescription for the management of gastrointestinal and skin symptoms in cancer patients by advanced practice nurses in China: a Delphi method.

IF 2.3 3区医学 Q1 MEDICINE, GENERAL & INTERNAL

BMJ Open Pub Date : 2025-03-31 DOI:10.1136/bmjopen-2024-089803

Zhiying Yue, Dan Zhou, Mingli Zeng, Junying Li, Rujun Zheng

{"title":"Drug prescription for the management of gastrointestinal and skin symptoms in cancer patients by advanced practice nurses in China: a Delphi method.","authors":"Zhiying Yue, Dan Zhou, Mingli Zeng, Junying Li, Rujun Zheng","doi":"10.1136/bmjopen-2024-089803","DOIUrl":null,"url":null,"abstract":"Background: The authority to prescribe drugs has been reserved only for the medical community, mainly clinicians. Recently, more and more countries worldwide have begun implementing reforms to grant advanced practice nurses (APNs) the authority to prescribe from the legislative level. This study aimed to explore the prescription drugs and forms for gastrointestinal and dermatological symptom management of cancer patients that APNs can prescribe in China.Design: A qualitative study reported in accordance with Conducting and REporting of DElphi Studies guidelines. The modified Delphi technique with two-round email consultations among 36 experts was applied.Methods: We conducted a study from January 2022 to March 2022 to reach a consensus among medical, nursing and pharmacy experts about drugs that nurses may prescribe for gastrointestinal and dermatological symptom management in cancer patients.Results: The expert authority coefficients are 0.95 and 0.96, respectively. A total of 35 drugs in 16 categories could be prescribed by APNs for gastrointestinal and dermatological symptoms management in China. Among them, three drugs were determined to be prescribed collaboratively, and 32 drugs were determined to be prescribed independently.Conclusions: The drug prescription formulated in this study is the basis for APNs to prescribe drugs for controlling gastrointestinal and skin symptoms for cancer patients in mainland China. The results are important as a guide for formulating and implementing policies related to nurse prescribing and will provide some reference for future nurse prescribing in China.","PeriodicalId":9158,"journal":{"name":"BMJ Open","volume":"15 3","pages":"e089803"},"PeriodicalIF":2.3000,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11962776/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ Open","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/bmjopen-2024-089803","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}

引用次数: 0

Abstract

Background: The authority to prescribe drugs has been reserved only for the medical community, mainly clinicians. Recently, more and more countries worldwide have begun implementing reforms to grant advanced practice nurses (APNs) the authority to prescribe from the legislative level. This study aimed to explore the prescription drugs and forms for gastrointestinal and dermatological symptom management of cancer patients that APNs can prescribe in China.

Design: A qualitative study reported in accordance with Conducting and REporting of DElphi Studies guidelines. The modified Delphi technique with two-round email consultations among 36 experts was applied.

Methods: We conducted a study from January 2022 to March 2022 to reach a consensus among medical, nursing and pharmacy experts about drugs that nurses may prescribe for gastrointestinal and dermatological symptom management in cancer patients.

Results: The expert authority coefficients are 0.95 and 0.96, respectively. A total of 35 drugs in 16 categories could be prescribed by APNs for gastrointestinal and dermatological symptoms management in China. Among them, three drugs were determined to be prescribed collaboratively, and 32 drugs were determined to be prescribed independently.

Conclusions: The drug prescription formulated in this study is the basis for APNs to prescribe drugs for controlling gastrointestinal and skin symptoms for cancer patients in mainland China. The results are important as a guide for formulating and implementing policies related to nurse prescribing and will provide some reference for future nurse prescribing in China.

查看原文本刊更多论文

中国高级执业护士对癌症患者胃肠道和皮肤症状的药物处方管理：德尔菲法

背景：开药的权力一直只保留给医学界，主要是临床医生。最近，世界上越来越多的国家开始实施改革，从立法层面赋予高级执业护士（apn）开处方的权力。本研究旨在探讨国内APNs可为癌症患者胃肠道及皮肤症状管理开出的处方药物及剂型。设计：根据德尔菲研究的指导和报告准则进行定性研究报告。采用改进的德尔菲法，对36名专家进行两轮电子邮件咨询。方法：我们于2022年1月至2022年3月进行了一项研究，以达成医学、护理和药学专家对护士在癌症患者胃肠道和皮肤症状管理中可能使用的药物的共识。结果：专家权威系数分别为0.95和0.96。在中国，apn可用于胃肠道和皮肤症状管理的药物共有16类35种。其中确定协同开处方3种，确定独立开处方32种。结论：本研究制定的药物处方是中国大陆地区APNs开具控制肿瘤患者胃肠道及皮肤症状药物的依据。研究结果对护士处方相关政策的制定和实施具有重要的指导意义，并为今后中国护士处方工作提供一定的参考。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

BMJ Open MEDICINE, GENERAL & INTERNAL-

CiteScore

4.40

自引率

3.40%

发文量

4510

审稿时长

2-3 weeks

期刊介绍： BMJ Open is an online, open access journal, dedicated to publishing medical research from all disciplines and therapeutic areas. The journal publishes all research study types, from study protocols to phase I trials to meta-analyses, including small or specialist studies. Publishing procedures are built around fully open peer review and continuous publication, publishing research online as soon as the article is ready.